Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Kidney Neoplasms | 19 | 2014 | 206 | 2.020 |
Why?
|
Lung Neoplasms | 29 | 2020 | 1172 | 1.940 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 14 | 2020 | 300 | 1.910 |
Why?
|
Carcinoma, Renal Cell | 18 | 2014 | 110 | 1.880 |
Why?
|
Chromosomes, Human, Pair 3 | 34 | 2014 | 56 | 1.840 |
Why?
|
Receptors, Cell Surface | 11 | 2014 | 248 | 1.190 |
Why?
|
Neuropilin-2 | 4 | 2022 | 19 | 1.080 |
Why?
|
Translocation, Genetic | 19 | 2014 | 74 | 1.020 |
Why?
|
Homeodomain Proteins | 9 | 2016 | 157 | 0.870 |
Why?
|
Cholesterol | 3 | 2012 | 331 | 0.760 |
Why?
|
Transcription Factors | 10 | 2016 | 753 | 0.730 |
Why?
|
Cadherins | 6 | 2010 | 93 | 0.660 |
Why?
|
Quinazolines | 4 | 2009 | 70 | 0.660 |
Why?
|
Membrane Proteins | 6 | 2009 | 617 | 0.620 |
Why?
|
Chromosomes, Artificial, Yeast | 14 | 2002 | 16 | 0.610 |
Why?
|
Chromosome Mapping | 25 | 2009 | 188 | 0.600 |
Why?
|
Antineoplastic Agents | 7 | 2020 | 1070 | 0.580 |
Why?
|
Gene Expression Regulation, Neoplastic | 5 | 2017 | 756 | 0.570 |
Why?
|
Protein Kinase Inhibitors | 4 | 2020 | 331 | 0.550 |
Why?
|
Ubiquitin-Protein Ligases | 3 | 2010 | 89 | 0.530 |
Why?
|
Tumor Cells, Cultured | 20 | 2016 | 852 | 0.500 |
Why?
|
Carcinoma, Small Cell | 6 | 1999 | 53 | 0.490 |
Why?
|
Transforming Growth Factor beta | 1 | 2017 | 384 | 0.470 |
Why?
|
Chromosome Deletion | 7 | 1997 | 41 | 0.460 |
Why?
|
Tumor Suppressor Proteins | 3 | 2005 | 194 | 0.460 |
Why?
|
Drosophila Proteins | 2 | 2005 | 44 | 0.450 |
Why?
|
Chromosomes, Human, Pair 8 | 11 | 2014 | 54 | 0.430 |
Why?
|
Restriction Mapping | 5 | 2002 | 85 | 0.420 |
Why?
|
Gene Amplification | 3 | 2009 | 71 | 0.410 |
Why?
|
Chromosomes, Human, Pair 12 | 5 | 1996 | 16 | 0.370 |
Why?
|
Sterols | 1 | 2010 | 13 | 0.360 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 7 | 2017 | 710 | 0.360 |
Why?
|
Protein Biosynthesis | 2 | 2010 | 181 | 0.350 |
Why?
|
Humans | 84 | 2022 | 68549 | 0.350 |
Why?
|
Blotting, Western | 7 | 2017 | 954 | 0.340 |
Why?
|
Genetic Markers | 15 | 1997 | 144 | 0.340 |
Why?
|
Eukaryotic Initiation Factor-3 | 1 | 2009 | 5 | 0.340 |
Why?
|
Molecular Sequence Data | 16 | 2014 | 1446 | 0.340 |
Why?
|
Genes, myc | 1 | 2009 | 26 | 0.340 |
Why?
|
Genes, Tumor Suppressor | 6 | 2009 | 61 | 0.330 |
Why?
|
Acid Anhydride Hydrolases | 6 | 2014 | 13 | 0.330 |
Why?
|
Lipid Metabolism | 1 | 2010 | 186 | 0.330 |
Why?
|
Zinc Finger E-box-Binding Homeobox 1 | 8 | 2016 | 22 | 0.310 |
Why?
|
Electrophoresis, Gel, Pulsed-Field | 5 | 2002 | 23 | 0.310 |
Why?
|
Cell Line, Tumor | 10 | 2017 | 1851 | 0.310 |
Why?
|
Neoplasm Proteins | 7 | 2014 | 307 | 0.310 |
Why?
|
Sirolimus | 2 | 2007 | 118 | 0.310 |
Why?
|
Liposarcoma | 3 | 1992 | 13 | 0.310 |
Why?
|
ErbB Receptors | 4 | 2016 | 239 | 0.300 |
Why?
|
DNA | 8 | 2002 | 597 | 0.300 |
Why?
|
Amino Acid Sequence | 7 | 2017 | 1082 | 0.300 |
Why?
|
DNA-Binding Proteins | 4 | 2009 | 700 | 0.280 |
Why?
|
Drug Resistance, Neoplasm | 3 | 2020 | 332 | 0.280 |
Why?
|
Obesity | 2 | 2012 | 1074 | 0.270 |
Why?
|
Proteins | 6 | 2003 | 473 | 0.270 |
Why?
|
Chromosomes, Fungal | 4 | 2002 | 14 | 0.260 |
Why?
|
Animals | 22 | 2022 | 20880 | 0.260 |
Why?
|
Ovarian Neoplasms | 4 | 2009 | 267 | 0.260 |
Why?
|
Metalloendopeptidases | 1 | 2005 | 67 | 0.250 |
Why?
|
Chromosome Fragility | 7 | 1998 | 10 | 0.250 |
Why?
|
Saccharomyces cerevisiae Proteins | 1 | 2005 | 123 | 0.240 |
Why?
|
Cell Line | 11 | 2014 | 1752 | 0.230 |
Why?
|
Blotting, Southern | 6 | 2001 | 67 | 0.230 |
Why?
|
Nerve Tissue Proteins | 4 | 2009 | 290 | 0.230 |
Why?
|
Epithelial-Mesenchymal Transition | 3 | 2016 | 135 | 0.220 |
Why?
|
Mutation | 9 | 2016 | 1213 | 0.210 |
Why?
|
Ligases | 1 | 2002 | 6 | 0.210 |
Why?
|
Kidney | 2 | 2006 | 945 | 0.200 |
Why?
|
Drosophila | 3 | 2010 | 37 | 0.200 |
Why?
|
Chromosomes, Human, Pair 16 | 2 | 1992 | 18 | 0.200 |
Why?
|
Sequence Homology, Amino Acid | 4 | 2017 | 230 | 0.200 |
Why?
|
Cell Proliferation | 5 | 2020 | 1174 | 0.190 |
Why?
|
Zinc Finger E-box Binding Homeobox 2 | 2 | 2010 | 5 | 0.180 |
Why?
|
Acrylamides | 1 | 2020 | 12 | 0.180 |
Why?
|
Von Hippel-Lindau Tumor Suppressor Protein | 5 | 2010 | 13 | 0.180 |
Why?
|
Aniline Compounds | 1 | 2020 | 52 | 0.180 |
Why?
|
Up-Regulation | 5 | 2013 | 682 | 0.180 |
Why?
|
Base Sequence | 11 | 2014 | 1015 | 0.180 |
Why?
|
Repetitive Sequences, Nucleic Acid | 5 | 1997 | 37 | 0.180 |
Why?
|
Lipids | 2 | 2012 | 298 | 0.170 |
Why?
|
Repressor Proteins | 2 | 2010 | 182 | 0.170 |
Why?
|
Signal Transduction | 5 | 2007 | 2689 | 0.160 |
Why?
|
Cloning, Molecular | 8 | 2006 | 357 | 0.160 |
Why?
|
Female | 25 | 2022 | 38021 | 0.160 |
Why?
|
Coleoptera | 1 | 2018 | 8 | 0.160 |
Why?
|
Chromosome Aberrations | 5 | 1994 | 86 | 0.160 |
Why?
|
Uterine Cervical Neoplasms | 2 | 2001 | 285 | 0.160 |
Why?
|
In Situ Hybridization, Fluorescence | 9 | 2000 | 144 | 0.160 |
Why?
|
DNA, Recombinant | 3 | 2001 | 25 | 0.150 |
Why?
|
RNA Interference | 2 | 2017 | 266 | 0.150 |
Why?
|
Protein Tyrosine Phosphatases | 3 | 1998 | 56 | 0.150 |
Why?
|
Saccharomyces cerevisiae | 3 | 2002 | 172 | 0.150 |
Why?
|
Neoplasms, Squamous Cell | 1 | 1997 | 8 | 0.150 |
Why?
|
Neovascularization, Pathologic | 3 | 2010 | 183 | 0.140 |
Why?
|
Mice | 7 | 2022 | 8474 | 0.140 |
Why?
|
Transplantation, Heterologous | 1 | 2017 | 122 | 0.140 |
Why?
|
Biomarkers, Tumor | 3 | 2012 | 508 | 0.140 |
Why?
|
Proto-Oncogene Proteins | 3 | 2004 | 411 | 0.140 |
Why?
|
Genetic Vectors | 2 | 2001 | 311 | 0.140 |
Why?
|
Gene Expression Profiling | 3 | 2010 | 498 | 0.140 |
Why?
|
Cytoskeletal Proteins | 2 | 2010 | 108 | 0.130 |
Why?
|
DNA Primers | 6 | 2005 | 302 | 0.130 |
Why?
|
Genome, Human | 3 | 1992 | 62 | 0.130 |
Why?
|
Endoplasmic Reticulum | 2 | 2009 | 148 | 0.130 |
Why?
|
Genomic Library | 2 | 1992 | 18 | 0.130 |
Why?
|
Survival Analysis | 1 | 2017 | 714 | 0.130 |
Why?
|
Disease Progression | 2 | 2017 | 1037 | 0.120 |
Why?
|
Inverted Repeat Sequences | 2 | 2014 | 4 | 0.120 |
Why?
|
RNA, Small Interfering | 3 | 2016 | 434 | 0.120 |
Why?
|
Neoplastic Syndromes, Hereditary | 2 | 2010 | 14 | 0.120 |
Why?
|
Histone Deacetylase Inhibitors | 3 | 2011 | 116 | 0.120 |
Why?
|
RNA, Messenger | 5 | 2016 | 1663 | 0.120 |
Why?
|
COP9 Signalosome Complex | 2 | 2005 | 2 | 0.120 |
Why?
|
Polymorphism, Genetic | 2 | 1997 | 301 | 0.120 |
Why?
|
Cricetinae | 5 | 2010 | 262 | 0.110 |
Why?
|
Gene Library | 2 | 1993 | 68 | 0.110 |
Why?
|
Male | 18 | 2017 | 37283 | 0.110 |
Why?
|
Chromosomes, Human, Pair 22 | 2 | 2010 | 18 | 0.110 |
Why?
|
Hydroxamic Acids | 2 | 2011 | 84 | 0.110 |
Why?
|
Refractometry | 1 | 2012 | 23 | 0.110 |
Why?
|
Transforming Growth Factor beta1 | 1 | 2013 | 126 | 0.110 |
Why?
|
Immunoassay | 1 | 2012 | 64 | 0.110 |
Why?
|
Cholesterol Esters | 1 | 2012 | 26 | 0.110 |
Why?
|
Cricetulus | 4 | 2010 | 98 | 0.110 |
Why?
|
Glycogen | 1 | 2012 | 27 | 0.110 |
Why?
|
Mevalonic Acid | 1 | 2012 | 27 | 0.110 |
Why?
|
Rats, Nude | 2 | 2009 | 5 | 0.110 |
Why?
|
Hypoxia-Inducible Factor 1, alpha Subunit | 2 | 2010 | 71 | 0.100 |
Why?
|
Biosensing Techniques | 1 | 2012 | 51 | 0.100 |
Why?
|
Breast Neoplasms | 1 | 2022 | 1533 | 0.100 |
Why?
|
Lipoma | 1 | 1992 | 24 | 0.100 |
Why?
|
Genetics, Medical | 2 | 2002 | 17 | 0.100 |
Why?
|
Aged | 7 | 2017 | 14842 | 0.100 |
Why?
|
Flow Cytometry | 2 | 2009 | 489 | 0.100 |
Why?
|
Benzamides | 2 | 2009 | 156 | 0.100 |
Why?
|
Zinc Fingers | 1 | 1990 | 17 | 0.100 |
Why?
|
Histone Deacetylases | 2 | 2009 | 99 | 0.090 |
Why?
|
Adult | 9 | 2017 | 21379 | 0.090 |
Why?
|
Genes | 1 | 1990 | 86 | 0.090 |
Why?
|
CHO Cells | 2 | 2010 | 161 | 0.090 |
Why?
|
Nondisjunction, Genetic | 1 | 2010 | 1 | 0.090 |
Why?
|
Meiosis | 1 | 2010 | 5 | 0.090 |
Why?
|
Hemangiosarcoma | 1 | 2010 | 23 | 0.090 |
Why?
|
Middle Aged | 9 | 2017 | 21119 | 0.090 |
Why?
|
Serine Endopeptidases | 1 | 2010 | 50 | 0.090 |
Why?
|
Protein Binding | 3 | 2010 | 1027 | 0.090 |
Why?
|
Sterol Regulatory Element Binding Proteins | 1 | 2010 | 1 | 0.090 |
Why?
|
Estrone | 1 | 2010 | 9 | 0.090 |
Why?
|
Gene Expression Regulation | 3 | 2005 | 1293 | 0.090 |
Why?
|
Lactams, Macrocyclic | 1 | 2009 | 7 | 0.090 |
Why?
|
Carcinoma | 1 | 2011 | 215 | 0.090 |
Why?
|
Benzoquinones | 1 | 2009 | 13 | 0.090 |
Why?
|
Dysgerminoma | 1 | 2009 | 9 | 0.090 |
Why?
|
Adiponectin | 1 | 2010 | 52 | 0.090 |
Why?
|
Protein Stability | 1 | 2010 | 89 | 0.090 |
Why?
|
Genetic Linkage | 7 | 1996 | 90 | 0.090 |
Why?
|
Metabolic Networks and Pathways | 1 | 2010 | 65 | 0.090 |
Why?
|
Ubiquitination | 1 | 2010 | 85 | 0.090 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 1 | 2010 | 58 | 0.090 |
Why?
|
Histocompatibility Antigens Class I | 1 | 2009 | 24 | 0.090 |
Why?
|
Major Histocompatibility Complex | 1 | 2009 | 34 | 0.090 |
Why?
|
HSP90 Heat-Shock Proteins | 1 | 2009 | 46 | 0.090 |
Why?
|
DNA Probes | 7 | 1996 | 57 | 0.090 |
Why?
|
Leptin | 1 | 2010 | 80 | 0.090 |
Why?
|
Molecular Chaperones | 1 | 2010 | 81 | 0.080 |
Why?
|
Oncogenes | 2 | 1989 | 71 | 0.080 |
Why?
|
Ubiquitin | 1 | 2009 | 74 | 0.080 |
Why?
|
Aged, 80 and over | 2 | 2017 | 4843 | 0.080 |
Why?
|
Cell Cycle | 2 | 2007 | 312 | 0.080 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2010 | 282 | 0.080 |
Why?
|
Protein Kinases | 2 | 2007 | 122 | 0.080 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2011 | 467 | 0.080 |
Why?
|
Pancreatic Neoplasms | 1 | 2011 | 332 | 0.080 |
Why?
|
Bronchi | 2 | 2000 | 59 | 0.080 |
Why?
|
Leukemia, Myeloid | 2 | 2004 | 39 | 0.080 |
Why?
|
TOR Serine-Threonine Kinases | 2 | 2007 | 118 | 0.080 |
Why?
|
Melanoma | 1 | 2011 | 335 | 0.080 |
Why?
|
Pyridines | 1 | 2009 | 261 | 0.080 |
Why?
|
Y Chromosome | 1 | 1987 | 5 | 0.080 |
Why?
|
Turner Syndrome | 1 | 1987 | 10 | 0.080 |
Why?
|
Cell Division | 2 | 2006 | 541 | 0.080 |
Why?
|
Mosaicism | 1 | 1987 | 21 | 0.080 |
Why?
|
Cells, Cultured | 4 | 2010 | 2673 | 0.070 |
Why?
|
G2 Phase | 1 | 2006 | 26 | 0.070 |
Why?
|
Chromosomes, Artificial, Bacterial | 2 | 2007 | 8 | 0.070 |
Why?
|
Disease Susceptibility | 1 | 2007 | 179 | 0.070 |
Why?
|
Carrier Proteins | 1 | 2010 | 597 | 0.070 |
Why?
|
Phenotype | 2 | 2010 | 946 | 0.070 |
Why?
|
Apoptosis | 2 | 2011 | 1641 | 0.070 |
Why?
|
Azacitidine | 1 | 1986 | 20 | 0.070 |
Why?
|
X Chromosome | 1 | 1986 | 28 | 0.070 |
Why?
|
Sequence Analysis, DNA | 4 | 2014 | 208 | 0.070 |
Why?
|
Mitogen-Activated Protein Kinases | 1 | 2007 | 250 | 0.070 |
Why?
|
Cyclooxygenase 2 | 1 | 2006 | 160 | 0.070 |
Why?
|
Gene Deletion | 2 | 1997 | 235 | 0.070 |
Why?
|
Dinoprostone | 1 | 2006 | 110 | 0.060 |
Why?
|
Yeasts | 1 | 2005 | 15 | 0.060 |
Why?
|
Phosphorylation | 3 | 2020 | 1200 | 0.060 |
Why?
|
Point Mutation | 1 | 2005 | 97 | 0.060 |
Why?
|
Drug Synergism | 1 | 2005 | 260 | 0.060 |
Why?
|
Chromosomes, Human, Pair 6 | 2 | 1995 | 20 | 0.060 |
Why?
|
Genes, Homeobox | 1 | 2004 | 15 | 0.060 |
Why?
|
Glycogen Synthase Kinase 3 beta | 2 | 2020 | 57 | 0.060 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2005 | 214 | 0.060 |
Why?
|
Receptor Protein-Tyrosine Kinases | 1 | 2004 | 100 | 0.060 |
Why?
|
Rats | 2 | 2009 | 5300 | 0.060 |
Why?
|
Neoplasms | 2 | 2001 | 1664 | 0.060 |
Why?
|
Carcinoma, Squamous Cell | 2 | 2000 | 624 | 0.060 |
Why?
|
Proto-Oncogene Proteins c-akt | 2 | 2020 | 331 | 0.050 |
Why?
|
Alleles | 3 | 2007 | 386 | 0.050 |
Why?
|
AT Rich Sequence | 2 | 2014 | 5 | 0.050 |
Why?
|
Wings, Animal | 1 | 2002 | 6 | 0.050 |
Why?
|
Neuropilin-1 | 1 | 2022 | 4 | 0.050 |
Why?
|
von Hippel-Lindau Disease | 2 | 1994 | 7 | 0.050 |
Why?
|
Loss of Heterozygosity | 2 | 2000 | 25 | 0.050 |
Why?
|
PTEN Phosphohydrolase | 2 | 2020 | 108 | 0.050 |
Why?
|
Bacteriophage lambda | 1 | 2002 | 7 | 0.050 |
Why?
|
3T3 Cells | 1 | 2002 | 124 | 0.050 |
Why?
|
Sepharose | 1 | 2002 | 18 | 0.050 |
Why?
|
Peptide Hydrolases | 1 | 2002 | 82 | 0.050 |
Why?
|
COS Cells | 1 | 2002 | 155 | 0.050 |
Why?
|
Muscle Proteins | 1 | 2002 | 94 | 0.050 |
Why?
|
Schizosaccharomyces | 1 | 2002 | 31 | 0.050 |
Why?
|
Cell Movement | 2 | 2020 | 630 | 0.050 |
Why?
|
Molecular Weight | 1 | 2002 | 358 | 0.050 |
Why?
|
Electrophoresis, Agar Gel | 3 | 1991 | 32 | 0.050 |
Why?
|
Microscopy, Fluorescence | 2 | 2005 | 261 | 0.050 |
Why?
|
Protein Structure, Tertiary | 1 | 2002 | 322 | 0.050 |
Why?
|
Protein Isoforms | 1 | 2022 | 246 | 0.050 |
Why?
|
Recombination, Genetic | 1 | 2001 | 62 | 0.050 |
Why?
|
Lymphocytes | 4 | 2009 | 228 | 0.050 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2002 | 216 | 0.050 |
Why?
|
Syndactyly | 2 | 1991 | 4 | 0.050 |
Why?
|
Facial Bones | 2 | 1991 | 10 | 0.050 |
Why?
|
Immunoenzyme Techniques | 2 | 2016 | 196 | 0.050 |
Why?
|
Karyotyping | 6 | 1994 | 74 | 0.050 |
Why?
|
Microsatellite Repeats | 2 | 1997 | 40 | 0.050 |
Why?
|
A549 Cells | 1 | 2020 | 50 | 0.050 |
Why?
|
Polymerase Chain Reaction | 6 | 1997 | 492 | 0.050 |
Why?
|
Skull | 2 | 1991 | 63 | 0.050 |
Why?
|
Mice, Nude | 2 | 2013 | 294 | 0.050 |
Why?
|
Transfection | 3 | 2007 | 782 | 0.040 |
Why?
|
Lung | 1 | 2005 | 849 | 0.040 |
Why?
|
Chromosome Fragile Sites | 6 | 1998 | 7 | 0.040 |
Why?
|
Trans-Activators | 1 | 2001 | 237 | 0.040 |
Why?
|
Homozygote | 2 | 1997 | 119 | 0.040 |
Why?
|
Proteolysis | 1 | 2020 | 97 | 0.040 |
Why?
|
Sequence Tagged Sites | 2 | 1997 | 2 | 0.040 |
Why?
|
Hybrid Cells | 6 | 1996 | 18 | 0.040 |
Why?
|
Neoplasm Invasiveness | 1 | 2020 | 369 | 0.040 |
Why?
|
Gene Duplication | 1 | 1998 | 12 | 0.040 |
Why?
|
Immunohistochemistry | 3 | 2009 | 1174 | 0.040 |
Why?
|
DNA, Neoplasm | 3 | 1997 | 95 | 0.040 |
Why?
|
DNA Restriction Enzymes | 3 | 1987 | 49 | 0.040 |
Why?
|
Methylation | 2 | 1990 | 56 | 0.040 |
Why?
|
Phosphoric Monoester Hydrolases | 1 | 1998 | 22 | 0.040 |
Why?
|
Enzyme Activation | 1 | 2020 | 791 | 0.040 |
Why?
|
North America | 1 | 2018 | 111 | 0.040 |
Why?
|
Chromosome Banding | 5 | 1989 | 24 | 0.040 |
Why?
|
Spinocerebellar Degenerations | 1 | 1997 | 1 | 0.040 |
Why?
|
Trinucleotide Repeats | 1 | 1997 | 8 | 0.040 |
Why?
|
Nucleic Acid Hybridization | 2 | 1987 | 95 | 0.040 |
Why?
|
Blepharophimosis | 1 | 1997 | 2 | 0.040 |
Why?
|
Amino Acid Metabolism, Inborn Errors | 1 | 1997 | 8 | 0.040 |
Why?
|
Blepharoptosis | 1 | 1997 | 7 | 0.040 |
Why?
|
Propionates | 1 | 1997 | 21 | 0.040 |
Why?
|
RNA-Binding Proteins | 1 | 1999 | 215 | 0.040 |
Why?
|
Chromosomes, Human, Pair 9 | 1 | 1997 | 23 | 0.040 |
Why?
|
In Situ Hybridization | 1 | 1997 | 201 | 0.040 |
Why?
|
Cerebellar Ataxia | 1 | 1996 | 8 | 0.040 |
Why?
|
Histiocytoma, Benign Fibrous | 1 | 1996 | 10 | 0.040 |
Why?
|
Rhabdomyosarcoma | 1 | 1996 | 36 | 0.040 |
Why?
|
Troponin C | 1 | 1996 | 2 | 0.030 |
Why?
|
Muscle Fibers, Slow-Twitch | 1 | 1996 | 7 | 0.030 |
Why?
|
Mitogen-Activated Protein Kinase 1 | 2 | 2007 | 150 | 0.030 |
Why?
|
Nerve Growth Factors | 1 | 1996 | 75 | 0.030 |
Why?
|
Mitogen-Activated Protein Kinase 3 | 2 | 2007 | 147 | 0.030 |
Why?
|
Neuroblastoma | 1 | 1996 | 109 | 0.030 |
Why?
|
Down-Regulation | 2 | 2009 | 447 | 0.030 |
Why?
|
Real-Time Polymerase Chain Reaction | 1 | 2016 | 209 | 0.030 |
Why?
|
DNA, Satellite | 1 | 1994 | 4 | 0.030 |
Why?
|
Chromosome Breakpoints | 1 | 2014 | 1 | 0.030 |
Why?
|
Transcription, Genetic | 2 | 2009 | 562 | 0.030 |
Why?
|
HeLa Cells | 2 | 2009 | 237 | 0.030 |
Why?
|
Angiomatosis | 2 | 1994 | 5 | 0.030 |
Why?
|
Gene Frequency | 1 | 1994 | 207 | 0.030 |
Why?
|
Leukemia | 1 | 1993 | 117 | 0.030 |
Why?
|
Silicon | 1 | 2012 | 20 | 0.030 |
Why?
|
Miniaturization | 1 | 2012 | 21 | 0.030 |
Why?
|
Genotype | 2 | 2010 | 785 | 0.030 |
Why?
|
Crystallization | 1 | 2012 | 57 | 0.030 |
Why?
|
Software | 1 | 1995 | 418 | 0.030 |
Why?
|
Fragile X Syndrome | 2 | 1998 | 17 | 0.030 |
Why?
|
Chromosomes, Human, Pair 21 | 1 | 1992 | 9 | 0.030 |
Why?
|
Staining and Labeling | 1 | 2012 | 144 | 0.030 |
Why?
|
Low Density Lipoprotein Receptor-Related Protein-1 | 1 | 1992 | 9 | 0.030 |
Why?
|
Databases, Factual | 1 | 1995 | 621 | 0.030 |
Why?
|
Urinary Bladder Neoplasms | 1 | 1993 | 138 | 0.030 |
Why?
|
Equipment Failure Analysis | 1 | 2012 | 121 | 0.030 |
Why?
|
Apolipoproteins | 1 | 1992 | 51 | 0.030 |
Why?
|
Wnt Proteins | 2 | 2003 | 57 | 0.030 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2013 | 235 | 0.030 |
Why?
|
Proteasome Inhibitors | 1 | 2011 | 29 | 0.020 |
Why?
|
Lactones | 1 | 2011 | 64 | 0.020 |
Why?
|
Child | 3 | 2010 | 6401 | 0.020 |
Why?
|
Equipment Design | 1 | 2012 | 500 | 0.020 |
Why?
|
Human Genome Project | 1 | 1991 | 4 | 0.020 |
Why?
|
Pyrroles | 1 | 2011 | 83 | 0.020 |
Why?
|
Drug Combinations | 1 | 2011 | 304 | 0.020 |
Why?
|
Mice, Transgenic | 1 | 2013 | 1033 | 0.020 |
Why?
|
Chromosome Breakage | 1 | 2010 | 6 | 0.020 |
Why?
|
Spermatogenesis | 1 | 2010 | 7 | 0.020 |
Why?
|
Health | 1 | 2010 | 26 | 0.020 |
Why?
|
Gene Dosage | 1 | 2010 | 47 | 0.020 |
Why?
|
Spermatozoa | 1 | 2010 | 75 | 0.020 |
Why?
|
Exons | 2 | 2001 | 122 | 0.020 |
Why?
|
ras Proteins | 1 | 2010 | 102 | 0.020 |
Why?
|
Dogs | 1 | 2010 | 490 | 0.020 |
Why?
|
Viral Envelope Proteins | 1 | 2009 | 43 | 0.020 |
Why?
|
Chromosomes, Human, Pair 7 | 1 | 1989 | 18 | 0.020 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2010 | 320 | 0.020 |
Why?
|
Response Elements | 1 | 2009 | 29 | 0.020 |
Why?
|
Prognosis | 2 | 2006 | 2093 | 0.020 |
Why?
|
Ovary | 1 | 2009 | 99 | 0.020 |
Why?
|
Heterozygote | 1 | 1989 | 174 | 0.020 |
Why?
|
Child, Preschool | 2 | 2010 | 3187 | 0.020 |
Why?
|
Recombinant Fusion Proteins | 1 | 2009 | 376 | 0.020 |
Why?
|
Vascular Endothelial Growth Factors | 1 | 2007 | 30 | 0.020 |
Why?
|
Smoking | 1 | 1996 | 1449 | 0.020 |
Why?
|
Siblings | 1 | 2007 | 34 | 0.020 |
Why?
|
Pedigree | 1 | 1987 | 159 | 0.020 |
Why?
|
STAT3 Transcription Factor | 1 | 2007 | 86 | 0.020 |
Why?
|
Erlotinib Hydrochloride | 1 | 2007 | 12 | 0.020 |
Why?
|
Binding Sites | 1 | 2009 | 631 | 0.020 |
Why?
|
Age of Onset | 2 | 1997 | 188 | 0.020 |
Why?
|
Calcium-Calmodulin-Dependent Protein Kinases | 1 | 2007 | 107 | 0.020 |
Why?
|
Aphidicolin | 3 | 1994 | 8 | 0.020 |
Why?
|
DNA, Fungal | 1 | 1986 | 20 | 0.020 |
Why?
|
Antibiotics, Antineoplastic | 1 | 2007 | 82 | 0.020 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2007 | 304 | 0.020 |
Why?
|
E-Box Elements | 1 | 2006 | 3 | 0.020 |
Why?
|
Cell Aggregation | 1 | 2006 | 28 | 0.020 |
Why?
|
Snail Family Transcription Factors | 1 | 2006 | 31 | 0.020 |
Why?
|
Philadelphia Chromosome | 1 | 1986 | 7 | 0.020 |
Why?
|
Nucleic Acid Conformation | 1 | 1986 | 92 | 0.020 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 1 | 1986 | 272 | 0.020 |
Why?
|
Risk | 1 | 1987 | 563 | 0.020 |
Why?
|
Genetic Predisposition to Disease | 1 | 2009 | 786 | 0.020 |
Why?
|
Genetic Therapy | 1 | 2007 | 291 | 0.020 |
Why?
|
Models, Genetic | 1 | 1986 | 161 | 0.020 |
Why?
|
Integrin alphaVbeta3 | 1 | 2005 | 15 | 0.020 |
Why?
|
Culture Media, Conditioned | 1 | 2005 | 78 | 0.020 |
Why?
|
Neoplasm Transplantation | 1 | 2005 | 160 | 0.020 |
Why?
|
Blotting, Northern | 2 | 1996 | 189 | 0.020 |
Why?
|
Integrins | 1 | 2005 | 115 | 0.020 |
Why?
|
CCAAT-Enhancer-Binding Protein-alpha | 1 | 2004 | 6 | 0.020 |
Why?
|
Gene Expression Regulation, Leukemic | 1 | 2004 | 29 | 0.020 |
Why?
|
fms-Like Tyrosine Kinase 3 | 1 | 2004 | 21 | 0.020 |
Why?
|
Inflammation | 1 | 2010 | 1030 | 0.010 |
Why?
|
Plasmids | 1 | 2005 | 258 | 0.010 |
Why?
|
Genetic Diseases, Inborn | 2 | 1996 | 24 | 0.010 |
Why?
|
Syndrome | 2 | 1997 | 255 | 0.010 |
Why?
|
Cell Adhesion | 1 | 2005 | 324 | 0.010 |
Why?
|
Promoter Regions, Genetic | 1 | 2006 | 614 | 0.010 |
Why?
|
Neoplasm Metastasis | 1 | 2005 | 306 | 0.010 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2005 | 219 | 0.010 |
Why?
|
Lithium | 1 | 2003 | 76 | 0.010 |
Why?
|
Glycogen Synthase Kinase 3 | 1 | 2003 | 64 | 0.010 |
Why?
|
Acute Disease | 1 | 2004 | 658 | 0.010 |
Why?
|
Catenins | 1 | 2002 | 8 | 0.010 |
Why?
|
Polymorphism, Restriction Fragment Length | 2 | 1994 | 44 | 0.010 |
Why?
|
Adenomatous Polyposis Coli Protein | 1 | 2002 | 14 | 0.010 |
Why?
|
Adolescent | 2 | 2010 | 8904 | 0.010 |
Why?
|
Cell Survival | 1 | 2005 | 901 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2006 | 1465 | 0.010 |
Why?
|
Polymorphism, Single-Stranded Conformational | 1 | 2001 | 5 | 0.010 |
Why?
|
Extracellular Matrix | 1 | 2005 | 493 | 0.010 |
Why?
|
Microfilament Proteins | 1 | 2002 | 102 | 0.010 |
Why?
|
gamma Catenin | 1 | 2001 | 11 | 0.010 |
Why?
|
Desmoplakins | 1 | 2001 | 14 | 0.010 |
Why?
|
Lymphatic Metastasis | 1 | 2002 | 274 | 0.010 |
Why?
|
beta Catenin | 1 | 2001 | 73 | 0.010 |
Why?
|
DNA Mutational Analysis | 1 | 2001 | 159 | 0.010 |
Why?
|
Cell Adhesion Molecules | 1 | 2002 | 199 | 0.010 |
Why?
|
Phosphoproteins | 1 | 2002 | 202 | 0.010 |
Why?
|
Lymph Nodes | 1 | 2002 | 258 | 0.010 |
Why?
|
Cell Line, Transformed | 1 | 2000 | 100 | 0.010 |
Why?
|
Cell Membrane | 1 | 2002 | 524 | 0.010 |
Why?
|
Platelet Endothelial Cell Adhesion Molecule-1 | 1 | 2000 | 29 | 0.010 |
Why?
|
Ki-67 Antigen | 1 | 2000 | 28 | 0.010 |
Why?
|
Neoplasm Staging | 1 | 2002 | 799 | 0.010 |
Why?
|
Fibroblasts | 2 | 1995 | 902 | 0.010 |
Why?
|
Survival Rate | 1 | 2002 | 1055 | 0.010 |
Why?
|
Conserved Sequence | 1 | 1999 | 67 | 0.010 |
Why?
|
Sequence Deletion | 1 | 1999 | 89 | 0.010 |
Why?
|
Evolution, Molecular | 1 | 1999 | 79 | 0.010 |
Why?
|
RNA Splicing | 1 | 1998 | 32 | 0.010 |
Why?
|
Bronchoscopy | 1 | 2000 | 147 | 0.010 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2000 | 231 | 0.010 |
Why?
|
Diterpenes | 2 | 1988 | 42 | 0.010 |
Why?
|
Endothelium, Vascular | 1 | 2000 | 371 | 0.010 |
Why?
|
Ataxin-7 | 1 | 1997 | 1 | 0.010 |
Why?
|
Genomic Imprinting | 1 | 1997 | 10 | 0.010 |
Why?
|
Carboxy-Lyases | 1 | 1997 | 5 | 0.010 |
Why?
|
Methylmalonyl-CoA Decarboxylase | 1 | 1997 | 2 | 0.010 |
Why?
|
Infertility, Female | 1 | 1997 | 25 | 0.010 |
Why?
|
Fluorescent Antibody Technique, Indirect | 1 | 1997 | 95 | 0.010 |
Why?
|
Sequence Homology, Nucleic Acid | 1 | 1997 | 95 | 0.010 |
Why?
|
HT29 Cells | 1 | 1997 | 42 | 0.010 |
Why?
|
Chemoprevention | 1 | 1997 | 26 | 0.010 |
Why?
|
Brazil | 1 | 1996 | 48 | 0.010 |
Why?
|
United Kingdom | 1 | 1996 | 152 | 0.010 |
Why?
|
Retinal Degeneration | 1 | 1997 | 75 | 0.010 |
Why?
|
Genetic Variation | 1 | 1997 | 220 | 0.010 |
Why?
|
Lung Diseases, Obstructive | 1 | 1996 | 20 | 0.010 |
Why?
|
Immunophenotyping | 1 | 1996 | 110 | 0.010 |
Why?
|
Age Distribution | 1 | 1996 | 319 | 0.010 |
Why?
|
Epithelium | 1 | 1996 | 172 | 0.010 |
Why?
|
Retina | 1 | 1997 | 252 | 0.010 |
Why?
|
Species Specificity | 1 | 1996 | 302 | 0.010 |
Why?
|
Oligonucleotide Probes | 1 | 1994 | 35 | 0.010 |
Why?
|
Hemangioblastoma | 1 | 1994 | 6 | 0.010 |
Why?
|
Pheochromocytoma | 1 | 1994 | 22 | 0.010 |
Why?
|
Adrenal Gland Neoplasms | 1 | 1994 | 26 | 0.010 |
Why?
|
Cerebellar Neoplasms | 1 | 1994 | 17 | 0.010 |
Why?
|
Metaphase | 1 | 1994 | 12 | 0.010 |
Why?
|
Interphase | 1 | 1994 | 19 | 0.010 |
Why?
|
Retinal Diseases | 1 | 1994 | 40 | 0.010 |
Why?
|
Clone Cells | 1 | 1993 | 67 | 0.010 |
Why?
|
Gene Expression | 1 | 1996 | 770 | 0.010 |
Why?
|
RNA | 1 | 1993 | 171 | 0.010 |
Why?
|
Infant, Newborn | 1 | 1996 | 2455 | 0.010 |
Why?
|
Infant | 1 | 1996 | 2891 | 0.010 |
Why?
|
Risk Factors | 1 | 2000 | 5720 | 0.010 |
Why?
|
Receptors, Antigen, T-Cell, gamma-delta | 1 | 1989 | 8 | 0.010 |
Why?
|
Chromosome Disorders | 1 | 1989 | 31 | 0.010 |
Why?
|
Receptors, Antigen, T-Cell | 1 | 1989 | 135 | 0.000 |
Why?
|
Chromosomes, Human, 6-12 and X | 1 | 1986 | 2 | 0.000 |
Why?
|